JP2020537487A - メチローム解析を用いる癌の検出及び分類 - Google Patents

メチローム解析を用いる癌の検出及び分類 Download PDF

Info

Publication number
JP2020537487A
JP2020537487A JP2020501564A JP2020501564A JP2020537487A JP 2020537487 A JP2020537487 A JP 2020537487A JP 2020501564 A JP2020501564 A JP 2020501564A JP 2020501564 A JP2020501564 A JP 2020501564A JP 2020537487 A JP2020537487 A JP 2020537487A
Authority
JP
Japan
Prior art keywords
dna
cell
cancer
free
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020501564A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020537487A5 (https=
Inventor
デ カルヴァルホ ダニエル ディニズ
デ カルヴァルホ ダニエル ディニズ
スコット ビクター ブラットマン
スコット ビクター ブラットマン
ラジャット シンガニア
ラジャット シンガニア
チャクラヴァルシー アンクール ラヴィナラヤナ
チャクラヴァルシー アンクール ラヴィナラヤナ
シュー イー シェン
シュー イー シェン
Original Assignee
ユニバーシティー ヘルス ネットワーク
ユニバーシティー ヘルス ネットワーク
シナイ ヘルス システム
シナイ ヘルス システム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティー ヘルス ネットワーク, ユニバーシティー ヘルス ネットワーク, シナイ ヘルス システム, シナイ ヘルス システム filed Critical ユニバーシティー ヘルス ネットワーク
Publication of JP2020537487A publication Critical patent/JP2020537487A/ja
Publication of JP2020537487A5 publication Critical patent/JP2020537487A5/ja
Priority to JP2023119203A priority Critical patent/JP2023139162A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F18/00—Pattern recognition
    • G06F18/20—Analysing
    • G06F18/24—Classification techniques
    • G06F18/241—Classification techniques relating to the classification model, e.g. parametric or non-parametric approaches
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00—Machine learning
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/08—Learning methods
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G16B5/20—Probabilistic models
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2522/00—Reaction characterised by the use of non-enzymatic proteins
    • C12Q2522/10—Nucleic acid binding proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/164—Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/20—Sequence assembly

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Theoretical Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Software Systems (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Computation (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioethics (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Computing Systems (AREA)
  • Mathematical Physics (AREA)
JP2020501564A 2017-07-12 2018-07-11 メチローム解析を用いる癌の検出及び分類 Pending JP2020537487A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023119203A JP2023139162A (ja) 2017-07-12 2023-07-21 メチローム解析を用いる癌の検出及び分類

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762531527P 2017-07-12 2017-07-12
US62/531,527 2017-07-12
PCT/CA2018/000141 WO2019010564A1 (en) 2017-07-12 2018-07-11 DETECTION AND CLASSIFICATION OF CANCER USING METHYLOME ANALYSIS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023119203A Division JP2023139162A (ja) 2017-07-12 2023-07-21 メチローム解析を用いる癌の検出及び分類

Publications (2)

Publication Number Publication Date
JP2020537487A true JP2020537487A (ja) 2020-12-24
JP2020537487A5 JP2020537487A5 (https=) 2021-08-19

Family

ID=65000926

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020501564A Pending JP2020537487A (ja) 2017-07-12 2018-07-11 メチローム解析を用いる癌の検出及び分類
JP2023119203A Pending JP2023139162A (ja) 2017-07-12 2023-07-21 メチローム解析を用いる癌の検出及び分類

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023119203A Pending JP2023139162A (ja) 2017-07-12 2023-07-21 メチローム解析を用いる癌の検出及び分類

Country Status (8)

Country Link
US (2) US12031184B2 (https=)
EP (1) EP3652741A4 (https=)
JP (2) JP2020537487A (https=)
KR (2) KR102628878B1 (https=)
CN (2) CN118600004A (https=)
BR (1) BR112020000681A2 (https=)
CA (1) CA3069754A1 (https=)
WO (1) WO2019010564A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102522067B1 (ko) * 2016-05-03 2023-04-13 유니버시티 헬스 네트워크 무-세포 메틸화된 dna의 포획 방법 및 이의 이용
MX2019007444A (es) 2016-12-22 2019-08-16 Guardant Health Inc Metodos y sistemas para analisis de moleculas de acido nucleico.
US12227737B2 (en) * 2017-07-12 2025-02-18 University Health Network Cancer detection and classification using methylome analysis
BR112020000681A2 (pt) 2017-07-12 2020-07-14 University Health Network detecção e classificação de cancro utilizando análise de metilome
US12428684B2 (en) * 2018-07-05 2025-09-30 Active Genomes Expressed Diagnostics Corp Methods for detecting and treating a tumorigenic phenotype of the liver
CN109097439A (zh) * 2018-09-04 2018-12-28 上海交通大学 一种检测少量样品全基因组dna甲基化的方法
US11891653B2 (en) 2019-09-30 2024-02-06 Guardant Health, Inc. Compositions and methods for analyzing cell-free DNA in methylation partitioning assays
CN114868191A (zh) * 2019-10-11 2022-08-05 格瑞尔有限责任公司 利用起源组织阈值的癌症分类
CN115087744A (zh) * 2019-11-06 2022-09-20 大学健康网络 用于无细胞MeDIP测序的合成加标对照及其使用方法
EP4617375A3 (en) * 2019-11-26 2025-10-29 Guardant Health, Inc. Methods, compositions and systems for improving the binding of methylated polynucleotides
WO2021119471A1 (en) * 2019-12-13 2021-06-17 Grail, Inc. Cancer classification using patch convolutional neural networks
CN111154846A (zh) * 2020-01-13 2020-05-15 四川大学华西医院 一种甲基化核酸的检测方法
CN119193839A (zh) * 2020-05-09 2024-12-27 广州燃石医学检验所有限公司 癌症预后方法
US12592321B2 (en) * 2020-06-19 2026-03-31 University Health Network Cancer detection and classification using methylome analysis
CA3182321A1 (en) * 2020-06-19 2021-12-23 Scott BRATMAN Multimodal analysis of circulating tumor nucleic acid molecules
AU2021292311A1 (en) * 2020-06-20 2023-02-16 Grail, Llc Detection and classification of human papillomavirus associated cancers
JP2023547620A (ja) 2020-10-23 2023-11-13 ガーダント ヘルス， インコーポレイテッド 分配および塩基変換を使用してｄｎａを解析するための組成物および方法
CN112382342A (zh) * 2020-11-24 2021-02-19 山西三友和智慧信息技术股份有限公司 一种基于集成特征选择的癌症甲基化数据分类方法
CN112820407B (zh) * 2021-01-08 2022-06-17 清华大学 利用血浆游离核酸检测癌症的深度学习方法和系统
CN116762132B (zh) * 2021-01-14 2026-03-31 深圳华大生命科学研究院 基于游离dna的疾病预测模型及其构建方法和应用
CN114507737A (zh) * 2022-03-22 2022-05-17 杭州医学院 一种石棉相关疾病甲基化标记物的检测引物组合、试剂盒及扩增子测序文库的构建方法
KR102491322B1 (ko) * 2022-03-29 2023-01-27 주식회사 아이엠비디엑스 암 진단을 위한 다중 분석 예측 모델의 제조 방법
CN119604623A (zh) * 2022-05-25 2025-03-11 阿黛拉公司 用于无细胞核酸处理的方法和系统
CN115274124B (zh) * 2022-07-22 2023-11-14 江苏先声医学诊断有限公司 一种基于数据驱动的肿瘤早筛靶向Panel和分类模型的动态优化方法
WO2024025831A1 (en) * 2022-07-25 2024-02-01 Grail, Llc Sample contamination detection of contaminated fragments with cpg-snp contamination markers
CN115132273B (zh) * 2022-08-01 2023-07-28 广州燃石医学检验所有限公司 一种肿瘤形成风险与肿瘤组织来源的评估方法及系统
CN117766028B (zh) * 2022-09-16 2025-03-11 深圳吉因加医学检验实验室 一种基于甲基化差异预测样本来源的方法及装置
CN115376616B (zh) * 2022-10-24 2023-04-28 臻和(北京)生物科技有限公司 一种基于cfDNA多组学的多分类方法及装置
WO2024091028A1 (ko) * 2022-10-28 2024-05-02 주식회사 클리노믹스 Cell-free dna를 이용한 건강 및 질병관리 시스템 및 방법
CN121569344A (zh) * 2023-07-14 2026-02-24 夸登特健康公司 使用来自液体活检的dna甲基化对结肠直肠肿瘤进行分类

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015536639A (ja) * 2012-09-20 2015-12-24 ザ チャイニーズ ユニバーシティ オブ ホンコン 血漿による胎児または腫瘍のメチロームの非侵襲的決定
WO2016115530A1 (en) * 2015-01-18 2016-07-21 The Regents Of The University Of California Method and system for determining cancer status

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004524030A (ja) 2001-02-23 2004-08-12 ザ ジョンズ ホプキンス ユニバーシティー スクール オブ メディシン 膵臓がんにおけるメチル化の異なる配列
US6818762B2 (en) 2001-05-25 2004-11-16 Maine Molecular Quality Controls, Inc. Compositions and methods relating to nucleic acid reference standards
CN102308212A (zh) * 2008-12-04 2012-01-04 加利福尼亚大学董事会 用于确定前列腺癌诊断和预后的材料和方法
EP2514836B1 (en) 2011-04-19 2016-06-29 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Prostate cancer markers
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
JP6681841B2 (ja) 2014-05-09 2020-04-15 ライフコーデックス アーゲー 特別な細胞タイプに由来するｄｎａの検出とそれに関連する方法
TWI813141B (zh) * 2014-07-18 2023-08-21 香港中文大學 Ｄｎａ混合物中之組織甲基化模式分析
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
DE102015009187B3 (de) 2015-07-16 2016-10-13 Dimo Dietrich Verfahren zur Bestimmung einer Mutation in genomischer DNA, Verwendung des Verfahrens und Kit zur Durchführung des Verfahrens
WO2017100356A1 (en) 2015-12-07 2017-06-15 Data4Cure, Inc. A method and system for ontology-based dynamic learning and knowledge integration from measurement data and text
KR102522067B1 (ko) 2016-05-03 2023-04-13 유니버시티 헬스 네트워크 무-세포 메틸화된 dna의 포획 방법 및 이의 이용
CN110168099B (zh) 2016-06-07 2024-06-07 加利福尼亚大学董事会 用于疾病和病症分析的无细胞dna甲基化模式
US12227737B2 (en) 2017-07-12 2025-02-18 University Health Network Cancer detection and classification using methylome analysis
BR112020000681A2 (pt) 2017-07-12 2020-07-14 University Health Network detecção e classificação de cancro utilizando análise de metilome
US20210156863A1 (en) 2017-11-03 2021-05-27 University Health Network Cancer detection, classification, prognostication, therapy prediction and therapy monitoring using methylome analysis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015536639A (ja) * 2012-09-20 2015-12-24 ザ チャイニーズ ユニバーシティ オブ ホンコン 血漿による胎児または腫瘍のメチロームの非侵襲的決定
WO2016115530A1 (en) * 2015-01-18 2016-07-21 The Regents Of The University Of California Method and system for determining cancer status

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NATURE PROTOCOLOLS, vol. 7, JPN7022001948, 2012, pages 617 - 636, ISSN: 0005142000 *

Also Published As

Publication number Publication date
EP3652741A1 (en) 2020-05-20
KR102628878B1 (ko) 2024-01-23
US20200308651A1 (en) 2020-10-01
US20220251665A1 (en) 2022-08-11
CN118600004A (zh) 2024-09-06
EP3652741A4 (en) 2021-04-21
CA3069754A1 (en) 2019-01-17
WO2019010564A1 (en) 2019-01-17
JP2023139162A (ja) 2023-10-03
KR102930572B1 (ko) 2026-02-24
US12031184B2 (en) 2024-07-09
BR112020000681A2 (pt) 2020-07-14
KR20240018667A (ko) 2024-02-13
KR20200032127A (ko) 2020-03-25
CN111094590A (zh) 2020-05-01

Similar Documents

Publication Publication Date Title
US20220251665A1 (en) Cancer detection and classification using methylome analysis
US12454724B2 (en) Methods and systems for high-depth sequencing of methylated nucleic acid
US20210156863A1 (en) Cancer detection, classification, prognostication, therapy prediction and therapy monitoring using methylome analysis
US12227737B2 (en) Cancer detection and classification using methylome analysis
JP2019521673A (ja) 疾患および状態の分析のためのセルフリーｄｎａメチル化パターン
JP7665659B2 (ja) 循環腫瘍核酸分子のマルチモーダル分析
US20250002904A1 (en) Methods and systems for generating sequencing libraries
US20250230507A1 (en) Methods and systems for cell-free nucleic acid processing
AU2024341199A1 (en) Methods and systems for methylation sequencing
WO2024216205A1 (en) Methods and systems for cell-free nucleic acid processing
WO2024192294A1 (en) Methods and systems for generating sequencing libraries
HK40112829A (zh) 使用甲基化组分析进行癌症检测和分类
US12592321B2 (en) Cancer detection and classification using methylome analysis
US20260125763A1 (en) Methods and systems for cell-free nucleic acid processing
WO2026000126A1 (zh) 组合物及用于富集经转换的cfDNA片段的方法
HK40092784A (zh) 循环肿瘤核酸分子的多模态分析
WO2026000128A1 (zh) 组合物及用于弥漫大b细胞淋巴瘤化疗疗效预测的方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200917

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20200917

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200917

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210709

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210709

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20210929

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20211006

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220426

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220427

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220720

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221026

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221122

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230322

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230721

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230728

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230908

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20250724

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20250730

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250922

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260109

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260415